Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymph node staging in prostatic carcinoma revisited.

Per-Uno Malmström1

  • 1Department of Urology, University Hospital, Uppsala, Sweden. per-uno.malmstrom@kirurgi.uu.se

Acta Oncologica (Stockholm, Sweden)
|September 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer.

Scandinavian journal of urology·2026
Same author

Corrigendum.

Scandinavian journal of urology·2026
Same author

Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study.

Frontiers in oncology·2025
Same author

Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort.

European urology open science·2025
Same author

Paradigm shift in the treatment of bladder cancer? The Swedish perspective.

Scandinavian journal of urology·2025
Same author

The Swedish cooperation.

Urologic oncology·2025

Prostate cancer patients often relapse due to ineffective lymph node staging. Extended lymph node dissection and new imaging techniques show promise for improving detection of metastases beyond standard areas.

Area of Science:

  • Urology
  • Oncology
  • Medical Imaging

Background:

  • Prostatic carcinoma recurrence impacts nearly one-third of patients post-surgery.
  • Current lymph node staging methods, including CT and NMR, are insufficient for accurate preoperative assessment.
  • Limited lymphadenectomy recommendations for low-risk patients (Gleason score <7, PSA <20 ng/ml) are based on outdated data.

Purpose of the Study:

  • To evaluate the effectiveness of current lymph node staging in prostatic carcinoma.
  • To explore advanced surgical and imaging techniques for improved lymph node metastasis detection.
  • To determine if enhanced staging translates to improved patient survival.

Main Methods:

  • Review of extended lymphadenectomy findings, identifying metastases in previously unexamined regions.

Related Experiment Videos

  • Assessment of novel imaging modalities: high-resolution MRI with magnetic nanoparticles and Positron Emission Tomography (PET) using specific tracers.
  • Evaluation of the sentinel lymph node (SLN) method for feasibility and accuracy.

    • Main Results:

    • Extended dissections reveal a higher incidence of lymph node metastases, with over half located outside routinely dissected areas.
    • The sentinel lymph node (SLN) method is feasible and confirms that the obturator region alone is inadequate for staging.
    • High-resolution MRI and PET scans show potential for detecting small, previously undetectable lymph node metastases.

    Conclusions:

    • Current lymph node staging for prostate cancer requires broader anatomical coverage.
    • Advanced imaging techniques and extended dissection show improved detection rates but require further trials to confirm survival benefits.
    • The role of new imaging modalities in replacing surgical dissection for lymph node staging is under active investigation.